FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 4.0.1  |  FHIR Version n/a  User: [n/a]

424905009: Agalsidase alfa (substance)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jan 2007. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
2640334013 Recombinant agalsidase alfa (substance) en Fully specified name Inactive Entire term case insensitive SNOMED CT core module
2644389018 Recombinant agalsidase alfa en Synonym Inactive Entire term case insensitive SNOMED CT core module
3688107019 Agalsidase alfa (substance) en Fully specified name Active Entire term case insensitive SNOMED CT core module
3688108012 Agalsidase alfa en Synonym Active Entire term case insensitive SNOMED CT core module
3780797017 Recombinant alpha-galactosidase en Synonym Active Entire term case insensitive SNOMED CT core module
63409101000001118 Agalsidase alfa en Synonym Inactive Only initial character case insensitive SNOMED CT United Kingdom Edition module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Agalsidase alfa Is a Alpha-galactosidase false Inferred relationship Existential restriction modifier
Agalsidase alfa Has disposition Hydrolase true Inferred relationship Existential restriction modifier
Agalsidase alfa Is a Galactosidase true Inferred relationship Existential restriction modifier
Agalsidase alfa Is a Recombinant protein true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing agalsidase alfa Has active ingredient True Agalsidase alfa Inferred relationship Existential restriction modifier 1
Agalsidase alfa Has active ingredient True Agalsidase alfa Inferred relationship Existential restriction modifier 1
Product containing only agalsidase alfa in parenteral dose form (medicinal product form) Has active ingredient True Agalsidase alfa Inferred relationship Existential restriction modifier 1
Product containing agalsidase alfa in parenteral dose form (medicinal product form) Has active ingredient True Agalsidase alfa Inferred relationship Existential restriction modifier 1
Agalsidase alfa 1mg/1ml solution for injection vials Has active ingredient False Agalsidase alfa Inferred relationship Existential restriction modifier
Agalsidase alfa 3.5mg/3.5ml solution for injection vials Has active ingredient False Agalsidase alfa Inferred relationship Existential restriction modifier
Replagal 1mg/1ml solution for injection vials (Shire Pharmaceuticals Ltd) Has active ingredient True Agalsidase alfa Inferred relationship Existential restriction modifier
Replagal 3.5mg/3.5ml solution for infusion vials (Takeda UK Ltd) Has active ingredient True Agalsidase alfa Inferred relationship Existential restriction modifier
Agalsidase alfa 3.5mg/3.5ml solution for injection vials 10 vial Has specific active ingredient True Agalsidase alfa Inferred relationship Existential restriction modifier
Replagal 3.5mg/3.5ml solution for infusion vials (Takeda UK Ltd) 1 vial Has specific active ingredient True Agalsidase alfa Inferred relationship Existential restriction modifier
Agalsidase alfa 3.5mg/3.5ml solution for injection vials Has specific active ingredient True Agalsidase alfa Inferred relationship Existential restriction modifier
Agalsidase alfa 3.5mg/3.5ml solution for injection vials 4 vial Has specific active ingredient True Agalsidase alfa Inferred relationship Existential restriction modifier
Replagal 3.5mg/3.5ml solution for infusion vials (Takeda UK Ltd) Has specific active ingredient True Agalsidase alfa Inferred relationship Existential restriction modifier
Replagal 3.5mg/3.5ml solution for infusion vials (Takeda UK Ltd) 4 vial Has specific active ingredient True Agalsidase alfa Inferred relationship Existential restriction modifier
Agalsidase alfa 3.5mg/3.5ml solution for injection vials 1 vial Has specific active ingredient True Agalsidase alfa Inferred relationship Existential restriction modifier
Replagal 3.5mg/3.5ml solution for infusion vials (Takeda UK Ltd) 10 vial Has specific active ingredient True Agalsidase alfa Inferred relationship Existential restriction modifier
Replagal 1mg/1ml solution for injection vials (Shire Pharmaceuticals Ltd) Has specific active ingredient True Agalsidase alfa Inferred relationship Existential restriction modifier
Replagal 1mg/1ml solution for injection vials (Shire Pharmaceuticals Ltd) 1 vial Has specific active ingredient True Agalsidase alfa Inferred relationship Existential restriction modifier
Agalsidase alfa 1mg/1ml solution for injection vials 1 vial Has specific active ingredient True Agalsidase alfa Inferred relationship Existential restriction modifier
Agalsidase alfa 1mg/1ml solution for injection vials Has specific active ingredient True Agalsidase alfa Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start